Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Cirrhosis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    October 2020
  1. KRONLAGE C, Hardmeier M, Bally S, Scholz MC, et al
    Muscle stiffness, gait instability, and liver cirrhosis in Wilson's disease.
    Lancet. 2020;396:990.
    PubMed    


    November 2019
  2. HARRISON SA, Bashir MR, Guy CD, Zhou R, et al
    Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2019 Nov 11. pii: S0140-6736(19)32517.
    PubMed     Abstract available


    August 2019
  3. LOW ESL, Patwala K, Apostolov R
    Dyspnoea, clubbing, cirrhosis, and bubbles in both sides of the heart suggests hepatopulmonary syndrome.
    Lancet. 2019;394:510.
    PubMed    


    March 2019
  4. LEVY S, Samuel D
    Prevention of decompensation in cirrhosis: a new youth for beta blockers.
    Lancet. 2019 Mar 22. pii: S0140-6736(19)30736.
    PubMed    


  5. VILLANUEVA C, Albillos A, Genesca J, Garcia-Pagan JC, et al
    beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)31875.
    PubMed     Abstract available


    February 2019
  6. CARRAT F, Fontaine H, Dorival C, Simony M, et al
    Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
    Lancet. 2019 Feb 11. pii: S0140-6736(18)32111.
    PubMed     Abstract available


    January 2019
  7. BRAILLON A
    Laennec's cirrhosis.
    Lancet. 2019;393:131-132.
    PubMed    


    November 2018
  8. SETO WK, Lo YR, Pawlotsky JM, Yuen MF, et al
    Chronic hepatitis B virus infection.
    Lancet. 2018;392:2313-2324.
    PubMed     Abstract available


  9. CARACENI P, Roncadori A, Bernardi M
    Questions in the design of ANSWER - Authors' reply.
    Lancet. 2018;392:1623-1624.
    PubMed    


  10. ROWE IA, Parker R
    Questions in the design of ANSWER.
    Lancet. 2018;392:1623.
    PubMed    


    July 2018
  11. BARNETT R
    Liver cirrhosis.
    Lancet. 2018;392:275.
    PubMed    


    May 2018
  12. GARCIA-TSAO G
    Long-term albumin in cirrhosis: is it the ANSWER?
    Lancet. 2018 May 31. pii: S0140-6736(18)30948.
    PubMed    


  13. CARACENI P, Riggio O, Angeli P, Alessandria C, et al
    Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
    Lancet. 2018 May 31. pii: S0140-6736(18)30840.
    PubMed     Abstract available


    February 2017
  14. HEGADE VS, Kendrick SF, Dobbins RL, Miller SR, et al
    Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.
    Lancet. 2017 Feb 7. pii: S0140-6736(17)30319.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: